EndoProtech Inc. develops novel liposome-based therapies for myocardial infarction and alcohol liver disease.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 1044 E Chestnut St, Louisville,kentucky,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Alcohol Liver Disease, Myocardial Infarction, Hepatitis, cirrhosis, No Reflow Phenomenon, Liposomes.
- HQ
- Louisville, Kentucky
Endoprotech, Inc. Questions
Endoprotech, Inc.'s LinkedIn profile is https://www.linkedin.com/company/endoprotechinc
Endoprotech, Inc. has
6 employees.
View email and phone details for 6
employees at Endoprotech, Inc..
Endoprotech, Inc.'s industry is
Biotechnology Research
Endoprotech, Inc.'s top competitors are
Segal,
Cognision,
Rade Llc,
Bexion Pharmaceuticals,
Aapptec,
Redleaf Biologics, Inc.,
Thorn Bioscience,
Bioengineering Department - University Of Louisville,
Comprehensive Cell Solutions (Ccs),
Biovico.
Endoprotech, Inc.'s categories are Biotechnology Research
Endoprotech, Inc.'s founding year is 2005
